Key result
PCOS is linked to greater P-wave maximum duration and dispersion versus healthy controls.
Why the study?
Polycystic ovary syndrome is associated with cardiac arrhythmias, but the relationship with P-wave durations and dispersion as predictors of atrial arrhythmias was unclear.
Does polycystic ovary syndrome increase P-wave duration and dispersion compared to healthy controls?
Case-Control (n=86)
Does polycystic ovary syndrome increase P-wave duration and dispersion compared to healthy controls?
Polycystic ovary syndrome is associated with prolonged P-wave maximum duration and increased P-wave dispersion, suggesting a potential increased risk for atrial arrhythmias such as atrial fibrillation.
BACKGROUND: The polycystic ovary syndrome (PCOS) is associated with various cardiac manifestations including cardiac arrhythmias. P-wave dispersion (Pdis) is an appealing marker for predicting the risk of developing atrial arrhythmias. The purpose of this study was to evaluate P-wave durations and Pdis in patients with PCOS. METHODS: Forty adult patients with PCOS and 46 age- and sex-matched healthy individuals were included in this study. P-wave maximum duration (Pmax) and P-wave minimum duration (Pmin) were calculated on the 12-lead electrocardiogram, and the difference between the Pmax and the Pmin was defined as Pdis. All individuals also underwent transthoracic echocardiographic evaluation. RESULTS: Pmax and Pdis were significantly higher in patients with PCOS compared with controls (p = 0.007, p < 0.001, respectively). There was no difference in Pmin duration between both the groups (p = 0.2). Waist-to-hip ratio, insulin and homeostasis model assessment of insulin resistance (HOMA-IR) were higher in the PCOS group. Early mitral inflow deceleration time (DT) (p < 0.001) and isovolumetric relaxation time (p = 0.003) were longer in PCOS group. Waist-to-hip ratio, DT, E/A ratio and diastolic blood pressure correlated with Pdis. CONCLUSIONS: Patients with PCOS have prolonged Pmax and Pdis. The increase in those parameters may be an indicator for identification of patients at increased risk of atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Erdoğan et al. (2013) conducted a case-control in Polycystic ovary syndrome (n=86). Polycystic ovary syndrome vs. Age- and sex-matched healthy individuals was evaluated on P-wave maximum duration (Pmax) and P-wave dispersion (Pdis) (p=0.007 for Pmax, <0.001 for Pdis). Polycystic ovary syndrome was associated with significantly higher P-wave maximum duration (p=0.007) and P-wave dispersion (p<0.001) compared with healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: